Abstract:BACKGROUND:MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene expression, influence cellular processes, and promote disease development. Variations in miRNA expression have been observed in many diseases, including hepatitis, cardiovascular disease, and cancer. The aim of this study is to investigate the effect of miR-144-3p on the invasion and metastasis of lung adenocarcinoma by targeting recombinant insulin receptor substrate 1 (IRS1).METHODS:The expression of miR-144-3p in patients with lung adenocarcinoma was queried through bioinformatics database. MirTarPathway was used to analyze the KEGG enrichment pathway of miRNA. The expression and plasmid transfection efficiency of miR-144-3p in lung adenocarcinoma cell lines were detected by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Transwell assay was used to detect the changes of cell invasion and migration ability in different groups. Bioinformatics determined the key genes (Hub genes) of miR-144-3p; Double luciferase target assay was used to detect the mutual binding of miR-144 and IRS1. Western blot assay was used to detect the expression of IRS1 in different cell lines and the expression of after overexpression of miR-144.RESULTS:The expression of miR-144-3p in lung adenocarcinoma tissues was decreased, qRT-PCR results indicated that the expression of miR-144-3p in lung adenocarcinoma cell A549 was significantly decreased (P<0.05), and the overexpressed plasmid was successfully transfected (P<0.05). Overexpression of miR-144 decreased the ability of cell migration and invasion (P<0.05). The expression of IRS1 was up-regulated in lung adenocarcinoma tissues. Survival analysis showed that patients with lung adenocarcinoma with high IRS1 expression had a poor prognosis (P<0.05). Double luciferase assay results showed that miR-144 could specifically identify 3'-UTR of IRS1 and inhibit reporter enzyme expression (P<0.05). Western blot indicated that the expression of IRS1 was increased in A549 cells (P<0.05). After overexpression of miR-144, the expression level of IRS1 protein was decreased (P<0.05). Transwell experiment proved that miR-144-3p could inhibit invasion and metastasis of lung adenocarcinoma cells by targeting IRS1 (P<0.05).CONCLUSIONS:MiR-144-3p inhibits the invasion and migration of A549 cells through targeted regulation of IRS1, thus playing an anticancer role in tumors.

Mir-409-3p Inhibits HT1080 Cell Proliferation, Vascularization and Metastasis by Targeting Angiogenin.

Tumor Cell-Secreted Angiogenin Induces Angiogenic Activity of Endothelial Cells by Suppressing Mir-542-3p

In Vivo Monitoring Of Angiogenesis Inhibition Via Down-Regulation Of Mir-21 In A Vegfr2-Luc Murine Breast Cancer Model Using Bioluminescent Imaging

Microrna-144-3p Suppresses Tumor Growth and Angiogenesis by Targeting Sgk3 in Hepatocellular Carcinoma

HOXD3 Targeted by Mir-203A Suppresses Cell Metastasis and Angiogenesis Through VEGFR in Human Hepatocellular Carcinoma Cells

Mir-337-3p Inhibits Gastric Tumor Metastasis by Targeting ARHGAP10

MiR-181b suppresses angiogenesis by directly targeting cellular communication network factor 1

Mir‑338‑3p Inhibits A549 Lung Cancer Cell Proliferation and Invasion by Targeting AKT and Β‑catenin Signaling Pathways.

[Mir-144-3p Inhibits the Invasion and Metastasis of Lung Adenocarcinoma Cells by Targeting IRS1].

Angiogenin promotes angiogenesis via the endonucleolytic decay of miR-141 in colorectal cancer

Inhibitory Effect of Mir-184 on the Potential of Proliferation and Invasion in Human Glioma and Breast Cancer Cells in Vitro.

Effect of Mir-146A-5p on Tumor Growth in NSCLC Using Chick Chorioallantoic Membrane Assay and Bioinformatics Investigation

Mir-218 Inhibited Tumor Angiogenesis by Targeting ROBO1 in Gastric Cancer.

Microrna-320B Suppresses HNF4G and IGF2BP2 Expression to Inhibit Angiogenesis and Tumor Growth of Lung Cancer.

Down-regulation of Microrna-338-3p Promoted Angiogenesis in Hepatocellular Carcinoma.

Downregulation of Mirna-638 Promotes Angiogenesis and Growth of Hepatocellular Carcinoma by Targeting VEGF

Mir-187-3p Inhibits the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting S100A4.

Mir-451 Acts As a Suppressor of Angiogenesis in Hepatocellular Carcinoma by Targeting the IL-6R-STAT3 Pathway.

MiR-145 Functions As a Tumor Suppressor Via Regulating Angiopoietin-2 in Pancreatic Cancer Cells.

Mir-371-5p Facilitates Pancreatic Cancer Cell Proliferation and Decreases Patient Survival

MiR-148b-3p Inhibits Renal Carcinoma Cell Growth and Pro-Angiogenic Phenotype of Endothelial Cell Potentially by Modulating FGF2.